Evolution VC Partners — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Betaliq is a clinical-stage pharmaceutical company developing topical eye-drop therapies for glaucoma using a licensed water-free drug delivery platform (EyeSol).
BiotechHealthtechMedical DevicesTarpon Springs, US
Oliver Schlueter(Executive Officer, Director)Barry Butler(Founder & Chief Executive Officer)Oliver Schluter(Executive Officer, Director)Oliver Schlüter(Chief Financial Officer)Ronil Patel(Chief Operating Officer)Haley Lemon(Executive Officer)
Co-investorsGreen Park & Golf Ventures
Blank Beauty makes custom, made-to-order nail polish, mixing each bottle to a shade the customer specifies (including from an uploaded photo) using an AI-assisted pigment-matching microfactory, with buyers able to name their own color.
AI & Machine LearningConsumerDirect to ConsumerCollierville, US
CHARLES C. BRANDON(Executive Officer)
Co-investorsGlobal BrainMarket Square VenturesRareBreed Ventures
Beaverton, US
Eric Gregg(Executive Officer, Director)Nathan Goff(Executive Officer, Director, Promoter)Aaron Green(Executive Officer, Director)
Co-investorsCanaan PartnersClocktower VenturesSozo VenturesUnion Square Ventures (USV)QED Investors
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.